Novo Nordisk, the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

A group of Canadian undergrads is using plants to revolutionize medicine. Faced with soaring drug prices and global shortages ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this.

A federal commission is calling for $15 billion in new financing to reinforce U.S. biotech leadership amid competition from ...

Trump previously floated a 25% tariff on all imported drugs, though they were unaffected by recent reciprocal levies.

Novo Nordisk is investing 6.4 billion reais in Brazil to enhance their manufacturing of drugs like Ozempic. The expansion in ...

Novo Nordisk will invest $1.09 billion in Brazil to enhance production of injectable drugs for obesity and diabetes. This ...

Clarkson didn’t reveal the exact pharmaceutical she used, but did confirm it’s not Ozempic. “Everybody thinks it’s Ozempic — it’s not — it’s something else, but it’s something ...

Semaglutide medications like Ozempic and Wegovy have exploded in popularity in recent years due to their effectiveness in diabetes control and weight loss. Research has revealed additional ...

Ozempic (semaglutide) is an injectable medication for managing type 2 diabetes, cardiovascular risks, and chronic kidney disease. The drug can cause disruption to your gastrointestinal tract ...